Peptide Initiative

Peptides · Peptide comparison

Apelin-13 vs TB-500

A natural heart hormone that helps your cardiovascular system work better and supports healthy blood flow throughout your body.

A powerful fragment of thymosin beta-4 that acts like your body's repair signal—speeding up healing of muscles, tendons, and tissues by promoting cell migration and new blood vessel growth right where you need it most.

  • Healing & Recovery
  • Healing & Recovery

At a glance

Quick comparison

Dose rangeApelin-13100–100 nmol/minTB-5002–2.5 mg
FrequencyApelin-13Once dailyTB-500Twice weekly
AdministrationApelin-13Intravenous (IV)TB-500Subcutaneous injection
Cycle lengthApelin-13Ongoing/indefiniteTB-5004-6 weeks
Onset speedApelin-13Moderate (1-2 weeks)TB-500Moderate (1-2 weeks)
Evidence levelApelin-13Moderate human trials (Phase 1-2)TB-500Moderate human trials (Phase 1-2)

Efficacy

Benefit ratings

Cardiovascular Support

Apelin-1382%
TB-500No recorded rating

Heart Function & Strength

Apelin-1378%
TB-500No recorded rating

Blood Flow & Circulation

Apelin-1374%
TB-500No recorded rating

Healing Speed

Apelin-13No recorded rating
TB-50095%

Tissue Repair

Apelin-13No recorded rating
TB-50093%

Anti-Scarring

Apelin-13No recorded rating
TB-50088%

Technical data

Compound specifications

Apelin-13

Molecular formula
C69H111N23O16S
Molecular weight
1550.8 Da
Half-life
Minutes in plasma; varies by route of administration
Bioavailability
~90-95% (subcutaneous injection)
CAS number
Not yet assigned (research compound)

TB-500

Molecular formula
C38H68N10O14
Molecular weight
889.01 g/mol
Half-life
2-3 days (systemic)
Bioavailability
High via subcutaneous injection (~100%)
CAS number
885340-08-9

Protocols

Dosing compared

Apelin-13

Intravenous

  • 30 nmol/minContinuous infusion · 5 minutes per dose step (research setting)Apelin-13 is a research peptide given as a short drip into a vein in studies, not by self-injection. This low rate was the first step tested in a human heart study. [4]
  • 100 nmol/minContinuous infusion · 5 minutes per dose step (research setting)Middle infusion rate used in the human heart study. It increased the heart's output and relaxed blood vessels. [4]
  • 300 nmol/minContinuous infusion · 5 minutes per dose step (research setting)Highest infusion rate tested in the same human study, producing the strongest effect on heart output and blood pressure. [4]

TB-500

Subcutaneous

  • 2-2.5 mgTwice weekly · Loading phase, 4-6 weeksResearch peptide with no human trials of the fragment; [9] loading doses used in practice [6].
  • 2-2.5 mgOnce weekly · Maintenance after loadingMaintenance dose used in practice following the loading phase [6].

Applications

Best suited for

Apelin-13

Research into cardiovascular health and heart function
Apelin-13 is particularly well-suited for individuals focused on research into cardiovascular health and heart function. Research and clinical experience suggest meaningful benefits in this area when used as part of a comprehensive treatment approach [4][7].
Understanding how the body naturally protects the heart
Apelin-13 is particularly well-suited for individuals focused on understanding how the body naturally protects the heart. Research and clinical experience suggest meaningful benefits in this area when used as part of a comprehensive treatment approach [3].
Exploring potential treatments for heart failure
Apelin-13 is particularly well-suited for individuals focused on exploring potential treatments for heart failure. Research and clinical experience suggest meaningful benefits in this area when used as part of a comprehensive treatment approach [4][7].
Studying mechanisms of heart muscle strength
Apelin-13 is particularly well-suited for individuals focused on studying mechanisms of heart muscle strength. Research and clinical experience suggest meaningful benefits in this area when used as part of a comprehensive treatment approach [4].

TB-500

Athletes Recovering from Muscle Injuries
If you've pulled a hamstring, strained your back, or torn a muscle, TB-500 helps accelerate the healing process by promoting cell migration to the injury site and supporting new blood vessel growth. It's especially useful for injuries that just won't seem to fully heal [1][5].
Tendon and Ligament Problems
Tendons and ligaments are notoriously slow healers because they have poor blood supply. TB-500 promotes angiogenesis (new blood vessel formation) and helps repair these stubborn connective tissue injuries—think Achilles tendonitis, tennis elbow, or rotator cuff issues [5].
Post-Surgical Recovery
After surgery, your body needs to repair a lot of tissue quickly. TB-500 supports wound healing, reduces inflammation, and may help minimize scar tissue formation. Some protocols use it alongside traditional recovery to potentially speed up the healing timeline [1][4].
Chronic Inflammation and Slow Healers
Some people just heal slowly—whether due to age, diabetes, or other factors. TB-500 helps regulate the inflammatory response and promotes the cellular processes needed for tissue repair. It essentially tells your body to focus healing resources where they're needed most [1].

Safety profile

Side effects

Apelin-13

Common

  • Mild changes in blood pressure
  • Minimal systemic effects in animal studies
  • Headache (theoretical, based on blood pressure effects)
  • Flushing or warmth at injection site
  • Mild inflammation at injection site
  • Dizziness if blood pressure drops too quickly
  • Allergic reactions to the peptide
  • Heart rhythm changes (requires monitoring)
  • Blood pressure, heart rate, cardiac function

Serious

  • Severe allergic reaction

TB-500

Common

  • Injection site redness
  • Mild fatigue or lethargy
  • Mild headache
  • Slight flushing

Uncommon

  • Head rush or lightheadedness
  • Temporary nausea

Serious

  • Allergic reaction

Research status

Safety & evidence

Apelin-13

Evidence level
Moderate human trials (Phase 1-2)
FDA status
Research compound
Safety overview
Apelin-13 is a research compound with no human clinical trials or FDA approval. All safety data comes from animal studies and in vitro mechanistic work showing beneficial effects on vascular function and cardiac remodeling. However, animal models do not predict human safety, and the peptide's effects on immune regulation in humans remain untested. No dose-ranging studies, pharmacokinetics, or organ accumulation data exist in humans. The APJ receptor is expressed in multiple tissues including brain, raising concerns about off-target neurological effects at high doses.

Contraindications

  • Currently under investigation - not for human clinical use
  • May interact with blood pressure medications (in theory)
  • Should not be used if allergic to peptides or component amino acids
  • Pregnant or breastfeeding individuals should avoid

TB-500

Evidence level
Moderate human trials (Phase 1-2)
FDA status
Research compound
Safety overview
TB-500 has shown a good safety profile across preclinical studies and limited human research. It's a fragment of thymosin beta-4, a naturally occurring protein in your body involved in healing. Most side effects are mild and transient, primarily injection site reactions. However, large-scale clinical trials are still needed to fully establish its safety profile in humans [1].

Contraindications

  • Pregnancy or planning to become pregnant
  • Currently breastfeeding
  • Active cancer or history of cancer
  • Known allergy to peptide components
  • Children and adolescents

Decision guide

Which is right for you?

Apelin-13

Choose Apelin-13 if…

  • Research into cardiovascular health and heart function
  • Understanding how the body naturally protects the heart
  • Exploring potential treatments for heart failure
  • Studying mechanisms of heart muscle strength

TB-500

Choose TB-500 if…

  • Accelerating injury recovery
  • Tendon and ligament healing
  • Reducing chronic inflammation
  • Post-surgical recovery support